Fujitsu establishes strategic research collaboration framework agreement with the Foundation for Biomedical Research of San Carlos Clinical Hospital (FIBHCSC)
Fujitsu Laboratories of Europe Ltd.
- Fujitsu Laboratories of Europe Ltd. and Fujitsu EMEIA in Spain are entering into a strategic research collaboration with the Foundation for Biomedical Research of San Carlos Clinical Hospital
- Research focus is on advanced knowledge fusion and informatics
- - First proof of concept addresses mental health issues, using data analytics to identify patterns and enable critical clinical decision-making
The formal framework agreement builds on a successful initial proof of concept project between Fujitsu and FIBHCSC, which is being demonstrated at Fujitsu Innovation Gathering 2015 (1). Focusing on mental illness, the proof of concept applies Fujitsu’s knowledge fusion to provide clinicians a new level of insight into with multi-faceted data. For example, the platform uses open data to reveal hidden correlations, identifying patients’ attendance patterns across heterogeneous clinical data silos and establishing demographic profiles of patients with mental health disorders. The proof of concept also provides exploratory analysis of complex datasets, delivering information via a rich and interactive visualization that promotes a better understanding of the multi-layered data involved.
Mental health was selected as a key target for the initial project due to the high levels of disability and mortality involved with mental illness, impacting heavily socially and on healthcare resources. Dr Julio Mayol Martínez, Director of Innovation at the FIBHCSC explains the importance of this first project: “We are constantly looking to identify new ways of improving how we deal with mental illness, which represents a heavy burden of disease in developed countries. We have access to a wealth of data, but it is difficult to extract meaningful information that helps us improve the care we deliver. This project applies an entirely new approach, using informatics to extract and visualize a range of useful information that can give clues as to the behavior of our patients. It is an important step forward, and we are working closely with Fujitsu to translate these initial results into broader integrated healthcare services in the future.”
For Angeles Delgado, Head of Fujitsu in Spain, the collaboration with FIBHCSC reflects Fujitsu’s focus on translating innovation into tangible solutions that benefit society and business, commenting: “We are delighted to cement the relationship between Fujitsu and FIBHCSC with this formal research collaboration framework agreement, and we are already looking at new areas of research. The mental health project is the first component in a larger program, looking at applying informatics to create a truly integrated healthcare solution. Our aim is to achieve solutions that benefit society as well as contributing to Fujitsu’s business, and our ongoing partnership with FIBHCSC is an ideal realization of this.”
Commenting on the research collaboration, Dr Adel Rouz, Executive Vice President of Fujitsu Laboratories of Europe said: “We are delighted to be working with FIBHCSC to help realize its long-term strategic objectives. This partnerhship is closely aligned to Fujitsu Laboratories’ mission to transfer technologies into innovative solutions that benefit society and improve lives. This important collaboration with FIBHCSC and our colleagues in Fujitsu in Spain is an example of how open innovation can be applied to accelerate the process, achieving rapid results to solve real-world problems.” With regard to the first collaboration, the mental health sector informatics project, we are looking forward to extending this further, aiming eventually to cover every clinical area across multiple departmental perspectives – such as managers, clinicians and patients. By establishing a genuinely value-based system, the objective is to enable evidence-based decisions for the provision of genuinely integrated healthcare services.”
A second project is already under review, involving faster and more efficient cancer detection, deploying Fujitsu’s medical image registration technology for comparing nodules’ temporal changes. The technology has the potential to increase the accuracy and efficiency of radiologists assessing the evolution of tumors. This could subsequently benefit the outcomes for patients, accelerating cancer detection and achieving far greater image registration accuracy than before,with over 80% compared to 33% with previous systems in tests involving cases of pulmonary disease.
Fujitsu is the leading Japanese information and communication technology (ICT) company, offering a full range of technology products, solutions, and services. Approximately 159,000 Fujitsu people support customers in more than 100 countries. We use our experience and the power of ICT to shape the future of society with our customers. Fujitsu Limited (TSE: 6702) reported consolidated revenues of 4.8 trillion yen (US$40 billion) for the fiscal year ended March 31, 2015. For more information, please see http://www.fujitsu.com.
About Fujitsu Laboratories of Europe
Established in 2001 and with an active presence in Europe since 1990, Fujitsu Laboratories of Europe Limited represents Fujitsu Laboratories across EMEIA, focusing on regional initiatives that reflect the diverse mix of countries and ideologies. Fujitsu Laboratories of Europe is focused on the creation of cutting-edge solutions that benefit society, working with customers, collaboration partners and society as a whole to drive the evolution of information communication technologies. It works on the principle of open innovation, with particular emphasis on Future Networking, Big Data Analytics, the Internet of Things, Social Innovations, and Supercomputer Applications, please see http://www.fujitsu.com/uk/fle/.
Garrett Axford Ltd (on behalf of Fujitsu Laboratories of Europe Ltd)
Phone: +44 1903 854900
Company:Garrett Axford Ltd
Georgina Garrett, Director
All company or product names mentioned herein are trademarks or registered trademarks of their respective owners. Information provided in this press release is accurate at time of publication and is subject to change without advance notice.
Date: 09 June, 2015
City: London and Madrid
Fujitsu Laboratories of Europe Ltd.